Over 10 years of experience as a sell side analyst covering Big Pharma names. Specialize in contrarian calls with a very good success rate. Now working as buy side analyst with a proprietary fund.

which is a few years from now,” Reuters noted quoting Systematix analyst Vishal Manchanda. “They will also be available at a much lower price by generic drugmakers.” Citing Cipla Global CEO ...

Photo: Reuters/Arnd Wiegmann “They (Adar and Serum) are trying to fruitfully deploy the large cash pile that the company would have generated from the vaccine sales,” said Vishal Manchanda ...

Are you searching for information about New Vishal Dental Clinic in Gurugram (Gurgaon), Haryana. Medindia's directory provides you the contact details of such as telephone numbers, email address ...

"They (Adar and Serum) are trying to fruitfully deploy the large cash pile that the company would have generated from the vaccine sales," said Vishal Manchanda, research analyst at Systematix ...

Vishal Manchanda, Senior Vice-President (Institutional Research) with Systematix Group, observed that the US Biosecure Act (that looks to restrict US companies from working with some Chinese ...

Bigg Boss Tamil 8 starts with high drama as Pravitra Janani and VJ Vishal's heated argument over respect sets the stage for intense house dynamics. With 17 housemates adjusting after Sanchana ...

"They (Adar and Serum) are trying to fruitfully deploy the large cash pile that the company would have generated from the vaccine sales," said Vishal Manchanda, research analyst at Systematix ...

By Rishika Sadam and Hritam Mukherjee (Reuters) -Adar Poonawalla, CEO of vaccine maker Serum Institute of India, will buy a 50% stake in filmmaker Karan Johar's Dharma Productions for 10 billion ...

"They (Adar and Serum) are trying to fruitfully deploy the large cash pile that the company would have generated from the vaccine sales," said Vishal Manchanda, research analyst at Systematix ...